peak glp 1 Funnel plot for GLP-1 publication bias GLP-1 medications are a peptide
Description
Why it matters: The program is designed for people with a BMI of 21 or higher, including many in the healthy weight range, as defined by the CDC (BMI of 18.5 to 24.9)
[DOI] [PubMed] [Google Scholar] 110.Lin M.C., Wright D.E., Hruby V.J., Rodbell M
DPP-4i extends the half-life of GLP-1, thereby enhancing insulin production and diminishing glucagon release, which leads to improved glycemic control in individuals with type 2 diabetes mellitus (T2DM) [9]
Pharmaceuticals (Basel, Switzerland)
doi: 10.1016/j.molmet.2017.02.002 37 KnerrPJMowerySADourosJDPremdjeeBHjollundKRHeYet al
